Version 1
: Received: 9 October 2023 / Approved: 13 October 2023 / Online: 17 October 2023 (10:37:05 CEST)
How to cite:
Kiss, B.; Neagos, C.M.; Jimborean, G.; Hédi Katalin, S.B.; Szathmary, M.; Neagos, A. Obstructive Sleep Apnea in Patients with Comorbidities and Neck Cancer-Clinical Review. Preprints2023, 2023101068. https://doi.org/10.20944/preprints202310.1068.v1
Kiss, B.; Neagos, C.M.; Jimborean, G.; Hédi Katalin, S.B.; Szathmary, M.; Neagos, A. Obstructive Sleep Apnea in Patients with Comorbidities and Neck Cancer-Clinical Review. Preprints 2023, 2023101068. https://doi.org/10.20944/preprints202310.1068.v1
Kiss, B.; Neagos, C.M.; Jimborean, G.; Hédi Katalin, S.B.; Szathmary, M.; Neagos, A. Obstructive Sleep Apnea in Patients with Comorbidities and Neck Cancer-Clinical Review. Preprints2023, 2023101068. https://doi.org/10.20944/preprints202310.1068.v1
APA Style
Kiss, B., Neagos, C.M., Jimborean, G., Hédi Katalin, S.B., Szathmary, M., & Neagos, A. (2023). Obstructive Sleep Apnea in Patients with Comorbidities and Neck Cancer-Clinical Review. Preprints. https://doi.org/10.20944/preprints202310.1068.v1
Chicago/Turabian Style
Kiss, B., Mioara Szathmary and Adriana Neagos. 2023 "Obstructive Sleep Apnea in Patients with Comorbidities and Neck Cancer-Clinical Review" Preprints. https://doi.org/10.20944/preprints202310.1068.v1
Abstract
Introduction and objectives Obstructive sleep apnea (OSA) is defined as a cause of daytime sleepiness, as well as a clinical manifestation of sleep-disordered breathing. In the literature, there are numerous controversial studies regarding the etiology of this condition, but it is universally accepted that a significant role in its onset is played by the reduced activity of the upper airway muscles. Additionally, OSA has been associated with a series of comorbidities, such as type II diabetes, metabolic syndrome, cardiovascular and pulmonary conditions, as well as head and neck tumors, especially oropharyngeal and laryngeal tumors. The purpose of this review is to examine and demonstrate the prevalence of OSA in patients with associated pathologies, especially in patients with head and neck tumors, as well as the role of surgical and non-surgical therapeutic methods in improving the quality of life. Material and methods Taking into consideration the stated objective, a systematic analysis of the available literature was conducted, encompassing PubMed, Medline and Scopus databases. The evaluation was based on several keywords, including head and neck cancer, diabetes, diabetic, overlap syndrome, cardiovascular conditions, laryngeal neoplasm, radiotherapy, chemotherapy, as well as the concept of quality of life in laryngectomized patients and patients with OSA. Results Our results demonstrate the involvement of OSA in the presence of comorbidities and also, an increased incidence of OSA in patients with laryngeal cancer. It is important to note that surgical and post-surgical treatment can play a significant role in triggering OSA in these patients. Conclusions The clinician must recognize the increased prevalence of OSA in patients with head and neck cancer, as well as the coexistence of OSA with certain comorbidities. They should actively engage in early diagnosis and establish optimal treatment methods to improve the quality of life for patients with associated conditions such as head and neck tumors or cardiovascular pathology.
Keywords
obstructive sleep apnea; head and neck cancer; hypermetabolic syndrome; cardiovascular deases; stroke
Subject
Medicine and Pharmacology, Otolaryngology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
